Skip to content

Viva Biotech Holdings Sustainability Reports

Viva Biotech Holdings operates a leading contract research organization (CRO) and contract development and manufacturing organization (CDMO) platform. It provides structure-based drug discovery, preclinical development, and commercial manufacturing services to global biopharmaceutical innovators.

Sector: Professional & technical services

Country: China

Exchange: Hong Kong Stock Exchange

ISIN: KYG9390W1015

13 reports from 2019 to 2025